Read CEO Colin Hill’s latest Healthcare 2020 blog post “Beyond the $1,000 Genome” on Forbes.com.…

Lori Valigra of Mass High Tech reports on “The Future of the Personal Genome” panel at MIT featuring CEO Colin Hill, George Church (Harvard), Jamie Heywood (PatientsLikeMe) and Michael Pellini (Foundation Medicine). Personal genomes, which are quickly heading toward the $1,000 mark, could dramatically improve targeted, personalized treatments for patients with cancer or other illnesses, but it could take another five to 10 years before they pick up traction in the healthcare market……

Read CEO Colin Hill’s Healthcare 2020 blog post “Musings from the Mobile Health Summit with Carol McCall” on Forbes.com.…

Read CEO Colin Hill’s Healthcare 2020 blog post “From Burden to Bonanza” on Forbes.com.…

FierceBiotech IT covers the launch of GNS Healthcare CEO Colin Hill’s new blog in Forbes Magazine.…

CEO and co-founder Colin Hill launched “Healthcare 2020″ at Forbes.com. The blog will discuss core challenges facing healthcare from the perspective of accelerating technological advances including breakthroughs in Big Data analytics. Read the first post “Can Big Data Fix Healthcare?“…

GNS Healthcare was recognized as a company at the forefront of innovation in Massachusetts by NaviNet, America’s largest real-time healthcare communications network. In an article published Oct. 12, GNS was praised for its ability to drive change in the healthcare IT world.

 …

…

FierceBiotech IT profiles’ GNS Healthcare’s industry-leading technology and the benefits of the GNS Healthcare approach, which doesn’t rely on previous findings in scientific literature to inform its analyses of large datasets.…

GNS Healthcare is profiled in an article entitled “Biotech Company Forges Path to High Performance Healthcare” in HPCWire.…